πŸ‡ΊπŸ‡Έ FDA
Patent

US 10548971

MERS-CoV vaccine

granted A61KA61K2039/53A61K39/12

Quick answer

US patent 10548971 (MERS-CoV vaccine) held by Inovio Pharmaceuticals, Inc. expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/53, A61K39/12, A61K39/215, A61P